These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 30328895)

  • 1. Nuclear metallothionein in oral squamous cell carcinoma: clinicopathological parameters and patient survival.
    Bezerra GMDR; Pontes FSC; Conte Neto N; Nascimento LSD; Souza LL; Pinto Junior DDS; Pontes HAR
    Braz Oral Res; 2018 Oct; 32():e105. PubMed ID: 30328895
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ki-67 protein predicts survival in oral squamous carcinoma cells: an immunohistochemical study.
    Lopes VKM; Jesus AS; Souza LL; Miyahara LAN; Guimarães DM; Pontes HAR; Pontes FSC; Carvalho PL
    Braz Oral Res; 2017 Aug; 31():e66. PubMed ID: 28832714
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metallothionein expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patient survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    Histopathology; 2011 Sep; 59(3):514-25. PubMed ID: 22034891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. p-Akt and its relationship with clinicopathological features and survival in oral squamous cell carcinoma: an immunohistochemical study.
    Pontes HA; Pontes FS; de Jesus AS; Soares MC; Gonçalves FL; de Lucena Botelho T; do Carmo Ribeiro J; Dos Santos Pinto D
    J Oral Pathol Med; 2015 Aug; 44(7):532-7. PubMed ID: 25244056
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histone deacetylase-1 and -2 expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Alexandrou P; Sastre-Garau X
    J Oral Pathol Med; 2011 Oct; 40(9):706-14. PubMed ID: 21457345
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Overexpression of Hippo pathway effector TAZ in tongue squamous cell carcinoma: correlation with clinicopathological features and patients' prognosis.
    Wei Z; Wang Y; Li Z; Yuan C; Zhang W; Wang D; Ye J; Jiang H; Wu Y; Cheng J
    J Oral Pathol Med; 2013 Nov; 42(10):747-54. PubMed ID: 23551691
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Significance of galectins-1, -3, -4 and -7 in the progression of squamous cell carcinoma of the tongue.
    Alves PM; Godoy GP; Gomes DQ; Medeiros AM; de Souza LB; da Silveira EJ; Vasconcelos MG; Queiroz LM
    Pathol Res Pract; 2011 Apr; 207(4):236-40. PubMed ID: 21397408
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinicopathological prognostic factors of oral tongue squamous cell carcinoma: a retrospective study of 202 cases.
    Rodrigues PC; Miguel MC; Bagordakis E; Fonseca FP; de Aquino SN; Santos-Silva AR; Lopes MA; Graner E; Salo T; Kowalski LP; Coletta RD
    Int J Oral Maxillofac Surg; 2014 Jul; 43(7):795-801. PubMed ID: 24583139
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fibroblast growth factor receptor 4 protein expression and clinicopathological features in gastric cancer.
    Chen H; Shen DP; Zhang ZZ; Liu JH; Shen YY; Ni XZ
    World J Gastroenterol; 2015 Feb; 21(6):1838-44. PubMed ID: 25684949
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Evaluation of cannabinoid CB1 and CB2 receptors expression in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Giaginis C; Alexandrou P; Rodriguez J; Tasoulas J; Danas E; Patsouris E; Klijanienko J
    Tumour Biol; 2016 Mar; 37(3):3647-56. PubMed ID: 26459312
    [TBL] [Abstract][Full Text] [Related]  

  • 11. DNA base excision repair proteins APE-1 and XRCC-1 are overexpressed in oral tongue squamous cell carcinoma.
    Santana T; Sá MC; de Moura Santos E; Galvão HC; Coletta RD; Freitas RA
    J Oral Pathol Med; 2017 Aug; 46(7):496-503. PubMed ID: 27925687
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression and Clinical Significance of Concomitant FAK/SRC and p-Paxillin in Mobile Tongue Squamous Cell Carcinoma.
    Theocharis S; Kotta-Loizou I; Giaginis C; Alexandrou P; Danas E; Tsourouflis G; Tsoukalas N; Coutts RH; Tasoulas J; Klijanienko J
    Anticancer Res; 2017 Mar; 37(3):1313-1319. PubMed ID: 28314297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Fatty acid synthase expression in squamous cell carcinoma of the tongue: clinicopathological findings.
    Silva SD; Perez DE; Nishimoto IN; Alves FA; Pinto CA; Kowalski LP; Graner E
    Oral Dis; 2008 May; 14(4):376-82. PubMed ID: 18410580
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neurovascular Invasion and Histological Grade Serve as the Risk Factors of Cervical Lymph Node Metastases in Early Tongue Squamous Cell Carcinoma.
    Wu K; Yang X; Li L; Ruan M; Liu W; Lu W; Zhang C; Li S
    Mol Neurobiol; 2016 Jul; 53(5):2920-2926. PubMed ID: 25911199
    [TBL] [Abstract][Full Text] [Related]  

  • 15. EMMPRIN expression in tongue squamous cell carcinoma.
    Huang Z; Huang H; Li H; Chen W; Pan C
    J Oral Pathol Med; 2009 Jul; 38(6):518-23. PubMed ID: 19473445
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical and histopathologic independent prognostic factors in oral squamous cell carcinoma: a retrospective study of 334 cases.
    Arduino PG; Carrozzo M; Chiecchio A; Broccoletti R; Tirone F; Borra E; Bertolusso G; Gandolfo S
    J Oral Maxillofac Surg; 2008 Aug; 66(8):1570-9. PubMed ID: 18634942
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Expression of DNA repair proteins, MSH2, MLH1 and MGMT in mobile tongue squamous cell carcinoma: associations with clinicopathological parameters and patients' survival.
    Theocharis S; Klijanienko J; Giaginis C; Rodriguez J; Jouffroy T; Girod A; Point D; Tsourouflis G; Sastre-Garau X
    J Oral Pathol Med; 2011 Mar; 40(3):218-26. PubMed ID: 21029181
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression form of p53 and PCNA at the invasive front in oral squamous cell carcinoma: correlation with clinicopathological features and prognosis.
    Kato K; Kawashiri S; Yoshizawa K; Kitahara H; Okamune A; Sugiura S; Noguchi N; Yamamoto E
    J Oral Pathol Med; 2011 Oct; 40(9):693-8. PubMed ID: 21501231
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Increased expression of MCM5 is significantly associated with aggressive progression and poor prognosis of oral squamous cell carcinoma.
    Yu SY; Wang YP; Chang JY; Shen WR; Chen HM; Chiang CP
    J Oral Pathol Med; 2014 May; 43(5):344-9. PubMed ID: 24245508
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The expression and significance of MRP1, LRP, TOPOIIβ, and BCL2 in tongue squamous cell carcinoma.
    Zhang B; Liu M; Tang HK; Ma HB; Wang C; Chen X; Huang HZ
    J Oral Pathol Med; 2012 Feb; 41(2):141-8. PubMed ID: 21793937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.